AbCellera Biologics Inc. | ||||
NMS : ABCL || Location: Canada | ||||
$3.87-0.04 (-1.02%) |
0.98 M | 3.79 - 3.96 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 28, 2024 | 23.591 M |
March 15, 2024 | 23.039 M |
Feb. 29, 2024 | 22.785 M |
Feb. 15, 2024 | 22.814 M |
Jan. 31, 2024 | 24.489 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.13 | -0.17 | -26.02% |
09/30/2023 | -0.14 | -0.10 | 27.06% |
06/30/2023 | -0.13 | -0.11 | 17.04% |
03/31/2023 | -0.14 | -0.14 | -1.16% |
12/31/2022 | -0.01 | -0.10 | -1751.85% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 292.782M | Shares Float | 191.758M |
Short Float | 23.591M | Market Cap | 1144.78M |
Institution ownership | 43.65% | Insider ownership | 28.089% |
Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
Trailing EPS | -0.51 | Forward EPS | -0.69 |